Bosentan Improves Quality Of Life For Patients With Pulmonary Hypertension

ScienceDaily (Dec. 31, 1969) — Recent studies have shown that bosentan therapy greatly improves the quality of life for patients with pulmonary arterial hypertension (PAH). According to a study in Respirology published by Wiley-Blackwell, treatments with oral Bosentan reduces resistance in blood flow – allowing the heart and lungs to work more efficiently and in turn, enables patients to increase exercise capacity and quality... [read full story]